NJ-Based Watson Buying Generic Drugmaker ActavisWatson Pharmaceuticals Inc. is buying another generic drugmaker, Switzerland's Actavis Group, for about $5.6 billion in a move that will make Watson the world's third-biggest generic drugmaker.Associated PressAssociated Press